Covered recipient · General Payments record
CHISATO NISHIKAWA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$603.96
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $515.46 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $183.35 | 10 |
| PFIZER INC. | $100.52 | 6 |
| Lilly USA, LLC | $64.37 | 3 |
| Amgen Inc. | $52.68 | 3 |
| Acerta Pharma LLC | $42.75 | 2 |
| Astellas Pharma US Inc | $23.41 | 1 |
| GlaxoSmithKline, LLC. | $16.26 | 1 |
| SHIELD THERAPEUTICS INC | $16.10 | 1 |
| Exact Sciences Corporation | $16.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.98 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111662959 | CMS |
| Amgen Inc. | $15.90 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340493 | CMS |
| Amgen Inc. | $17.80 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340495 | CMS |
| Astellas Pharma US Inc | $23.41 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139428406 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.46 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104215177 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.29 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105832939 | CMS |
| Exact Sciences Corporation | $16.02 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114810783 | CMS |
| GlaxoSmithKline, LLC. | $16.26 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116583913 | CMS |
| Lilly USA, LLC | $18.91 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136117675 | CMS |
| Lilly USA, LLC | $20.83 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136106271 | CMS |
| Lilly USA, LLC | $24.63 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136117673 | CMS |
| Novo Nordisk Inc | $23.51 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096844143 | CMS |
| Novo Nordisk Inc | $20.63 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097036608 | CMS |
| Novo Nordisk Inc | $19.22 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096577029 | CMS |
| Novo Nordisk Inc | $8.38 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097358843 | CMS |
| Novo Nordisk Inc | $23.07 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096967215 | CMS |
| Novo Nordisk Inc | $28.99 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096953713 | CMS |
| Novo Nordisk Inc | $12.20 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096887242 | CMS |
| Novo Nordisk Inc | $7.59 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097096637 | CMS |
| Novo Nordisk Inc | $17.20 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096587615 | CMS |
| Novo Nordisk Inc | $22.56 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096959885 | CMS |
| PFIZER INC. | $14.88 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131910640 | CMS |
| PFIZER INC. | $17.46 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131913029 | CMS |
| PFIZER INC. | $19.63 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131995843 | CMS |
| PFIZER INC. | $15.64 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131924648 | CMS |
| PFIZER INC. | $16.43 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132092044 | CMS |
| PFIZER INC. | $16.48 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131170994 | CMS |
| SHIELD THERAPEUTICS INC | $16.10 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150155574 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.